- Investing Ideas
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
BioGaia
Market Cap: SEK 11.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.60
7D
3.0%
1Y
20.7%
Vitrolife
Market Cap: SEK 12.1b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 89.60
7D
-1.6%
1Y
-34.6%
Camurus
Market Cap: SEK 37.3b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 626.00
7D
0.6%
1Y
-7.1%
AddLife
Market Cap: SEK 19.1b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 156.70
7D
-1.4%
1Y
-8.1%
Bonesupport Holding
Market Cap: SEK 14.7b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 223.60
7D
-0.7%
1Y
-22.1%
BioArctic
Market Cap: SEK 28.6b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 322.60
7D
1.1%
1Y
36.9%
Swedish Orphan Biovitrum
Market Cap: SEK 161.3b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 464.60
7D
5.3%
1Y
66.3%